Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)
Status:
Terminated
Trial end date:
2015-10-14
Target enrollment:
Participant gender:
Summary
The purpose of the study is to find out if administration of danazol with plasma exchange and
corticosteroids will reduce the number of plasma exchanges required to control Thrombotic
Thrombocytopenic Purpura (TTP).
Phase:
Phase 2
Details
Lead Sponsor:
Beth Israel Medical Center Icahn School of Medicine at Mount Sinai
Collaborators:
Beth Israel Medical Center Icahn School of Medicine at Mount Sinai